169 related articles for article (PubMed ID: 14232726)
1. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
LINKE H
Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726
[No Abstract] [Full Text] [Related]
2. [Mydocalm, a new drug to relax spastic muscles in neurological diseases].
LEHOCZKY T
Ther Hung; 1961; 9():10-3. PubMed ID: 13929385
[No Abstract] [Full Text] [Related]
3. Successful use of mydocalm in peripheral arterial disease.
MOLNAR L
Ther Hung; 1962; 10():10-2. PubMed ID: 13935926
[No Abstract] [Full Text] [Related]
4. [Mydocalm and muscle tone].
DOBI S
Ther Hung; 1961; 9():15-8. PubMed ID: 14028214
[No Abstract] [Full Text] [Related]
5. [MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
BLONDEL F; COULEON M; COULEON H; ANNE L; CLERC G; COULOMBIER J; TRENQUALYEJP DE
Ann Med Psychol (Paris); 1964 Dec; 122():755-8. PubMed ID: 14252013
[No Abstract] [Full Text] [Related]
6. [EXPERIENCE IN THE USE OF NO-SPA, A NEW SPASMOLYTIC PREPARATION IN THE TREATMENT OF THROMBOOBLITERATIVE DISEASES IN THE LOWER EXTREMITIES].
ZOLOTAREVSKII VIa
Eksp Khir Anesteziol; 1964; 29():59-62. PubMed ID: 14161494
[No Abstract] [Full Text] [Related]
7. Observations with higher Mydocalm doses in outpatients of the surgical department.
Huber L
Ther Hung; 1986; 34(4):243-7. PubMed ID: 3449980
[No Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of occlusive arterial diseases].
Kaindl F
Wien Med Wochenschr; 1969 May; 119(18):333-40. PubMed ID: 5796630
[No Abstract] [Full Text] [Related]
9. [Spastic syndrome. More mobile again after stroke].
MMW Fortschr Med; 2001 Mar; 143(10):46. PubMed ID: 11268740
[No Abstract] [Full Text] [Related]
10. CONTROL OF SPASTIC STATES IN NEUROLOGICAL PATIENTS WITH DIAZEPAM.
FOWLKS EW; STRICKLAND DA; PEIRSON GA
Am J Phys Med; 1965 Feb; 44():9-19. PubMed ID: 14261634
[No Abstract] [Full Text] [Related]
11. [The effect of muscle relaxants in cerebral and spinal spastic states. Electromyographic and clinical studies].
STEINBRECHER W
Dtsch Med Wochenschr; 1959 Dec; 84():2295-8. PubMed ID: 13834180
[No Abstract] [Full Text] [Related]
12. [ISCHEMIC NEUROPATHY. NEUROLOGIC DISORDERS IN THE COURSE OF ARTERIAL OCCLUSIVE DISEASES IN THE AREA OF THE EXTREMITIES].
LINKE H
Z Gesamte Inn Med; 1964 Mar; 19():209-23. PubMed ID: 14172688
[No Abstract] [Full Text] [Related]
13. [ARTERIOLAR FUNCTIONAL DISORDERS IN OBLITERATING ARTERIOPATHIES].
CONDORELLI L
Cor Vasa; 1964; 6():178-93. PubMed ID: 14177017
[No Abstract] [Full Text] [Related]
14. [The treatment of trismus with special reference to the myotonolytic drug Mydocalm Richter].
Elze P
Dtsch Stomatol; 1966 Nov; 16(11):836-42. PubMed ID: 5225214
[No Abstract] [Full Text] [Related]
15. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
[No Abstract] [Full Text] [Related]
16. SPLINTING OF HAND IN A SPASTIC HEMIPLEGIC PATIENT.
ZISLIS JM
Arch Phys Med Rehabil; 1964 Jan; 45():41-3. PubMed ID: 14106086
[No Abstract] [Full Text] [Related]
17. [A study of mydocalm efficiency in the treatment of chronic headache of tension].
Solov'eva AD; Akarachkova ES; Gordeev SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(12):13-7. PubMed ID: 16450434
[TBL] [Abstract][Full Text] [Related]
18. [The use of mydocalm in the treatment of vascular diseases of the extremities].
Liubishchev SA
Klin Med (Mosk); 1967 Jan; 45(1):100-2. PubMed ID: 5613382
[No Abstract] [Full Text] [Related]
19. [EVALUATION OF THE VASODILATOR EFFECT OF INTRA-ARTERIAL MYDETON IN DOGS].
KELLER L; MOLNAR G; ZULIK R
Orv Hetil; 1964 Feb; 105():250-1. PubMed ID: 14139726
[No Abstract] [Full Text] [Related]
20. Observations with Mydocalm in angiological practice.
Balogh A
Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
